BackIonis Pharmaceuticals Overview
Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Target Price

Where could IONS trade next? Consensus target price: $76.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.06

Average Target Price

$75.50159.8% upside

20 analysts in the last 4 months

High: $115 | Low: $53

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-11-10RBC CapitalLuca Issi$60106.5% upsideOpen
2026-11-10TD CowenYaron Werber$5382.4% upsideOpen
2026-11-10Wells FargoYanan Zhu$80175.3% upsideOpen
2026-11-10Bank of America SecuritiesJason Gerberry$63116.8% upsideOpen
2026-11-09Raymond JamesTiago Fauth$5485.8% upsideOpen
2026-10-21BMO CapitalDavid Lebowitz$66127.1% upsideOpen
2026-10-20Raymond James$79171.9% upsideOpen
2026-10-15UBS$88202.8% upsideOpen
2026-09-24OppenheimerJay Olson$85192.5% upsideOpen
2026-09-15GuggenheimDebjit Chattopadhyay$80175.3% upsideOpen
2026-09-09Barclays$85192.5% upsideOpen
2026-09-08Raymond JamesTiago Fauth$84189.1% upsideOpen
2026-09-08Morgan StanleyMichael Ulz$104257.9% upsideOpen
2026-09-08Canaccord Genuity$85192.5% upsideOpen
2026-09-08BMO Capital$5485.8% upsideOpen
2026-09-08Goldman Sachs$5692.7% upsideOpen
2026-09-04BMO CapitalDavid Lebowitz$61109.9% upsideOpen
2026-07-30H.C. WainwrightMitchell Kapoor$115295.7% upsideOpen
2026-07-29Goldman Sachs$69137.4% upsideOpen
2026-07-21GuggenheimDebjit Chattopadhyay$89206.3% upsideOpen
2026-07-13RBC CapitalLuca Issi$85192.5% upsideOpen
2026-07-10Morgan Stanley$110278.5% upsideOpen
2026-07-10Canaccord GenuityGary Nachman$95226.9% upsideOpen
2026-07-10BarclaysEliana Merle$90209.7% upsideOpen
2026-07-09Jefferies$90209.7% upsideOpen
2026-07-09NeedhamJoseph Stringer$86195.9% upsideOpen
2026-07-09Raymond James$87199.4% upsideOpen
2026-06-25H.C. Wainwright$130347.4% upsideOpen
2026-06-24Goldman Sachs$75158.1% upsideOpen
2026-04-30Oppenheimer$111282% upsideOpen
2026-04-30H.C. Wainwright$125330.1% upsideOpen
2026-04-30BarclaysEliana Merle$115295.7% upsideOpen
2026-04-21Morgan Stanley$130347.4% upsideOpen
2026-04-20Canaccord Genuity$110278.5% upsideOpen
2026-04-10Raymond JamesTiago Fauth$104257.9% upsideOpen
2026-02-25Morgan StanleyMichael Ulz$95226.9% upsideOpen
2026-02-25Needham$103254.4% upsideOpen
2026-02-06Piper Sandler$87199.4% upsideOpen
2026-01-05Wells Fargo$100244.1% upsideOpen
2025-12-17RBC CapitalLuca Issi$95226.9% upsideOpen
2025-12-15Leerink Partners$100244.1% upsideOpen
2025-11-04Piper Sandler$77165% upsideOpen
2025-10-30Cowen & Co.$99240.7% upsideOpen
2025-10-30H.C. Wainwright$100244.1% upsideOpen
2025-10-30Morgan Stanley$94223.5% upsideOpen
2025-10-30Barclays$95226.9% upsideOpen
2025-10-16Morgan Stanley$90209.7% upsideOpen
2025-10-08OppenheimerJustin Kim$90209.7% upsideOpen
2025-10-06Stifel Nicolaus$67130.6% upsideOpen
2025-09-26Goldman Sachs$65123.7% upsideOpen

Ionis Pharmaceuticals (IONS) FAQ

The latest target price for IONS is $76. Investors often review this figure alongside Ionis Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Ionis Pharmaceuticals trades near $29.06 while the consensus target sits at $76 (159.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting IONS's target price ($76), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ionis Pharmaceuticals's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.